These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2621422)

  • 21. Serum and urinary bile acids in patients with primary biliary cirrhosis.
    Samuelson K; Aly A; Johansson C; Norman A
    Scand J Gastroenterol; 1982 Jan; 17(1):121-8. PubMed ID: 7134826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.
    Nakashima T; Sano A; Seto Y; Nakajima T; Shima T; Sakamoto Y; Okuno T; Kashima K; Hasegawa T
    Hepatology; 1990 Feb; 11(2):255-60. PubMed ID: 2307404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
    Setchell KD; Rodrigues CM; Podda M; Crosignani A
    Gut; 1996 Mar; 38(3):439-46. PubMed ID: 8675100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotransformation of orally administered ursodeoxycholic acid in man as observed in gallbladder bile, serum and urine.
    Fischer S; Neubrand M; Paumgartner G
    Eur J Clin Invest; 1993 Jan; 23(1):28-36. PubMed ID: 8444272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster.
    Malavolti M; Fromm H; Ceryak S; Shehan KL
    Life Sci; 1990; 46(23):1727-37. PubMed ID: 2355803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum concentrations of ursodeoxycholic acid in portal venous and systemic venous blood of fasting humans as determined by isotope dilution-mass spectrometry.
    Ewerth S; Angelin B; Einarsson K; Nilsell K; Björkhem I
    Gastroenterology; 1985 Jan; 88(1 Pt 1):126-33. PubMed ID: 3880555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.
    Hedenborg G; Jönsson G; Wisén O; Norman A
    Scand J Clin Lab Invest; 1991 Apr; 51(2):197-208. PubMed ID: 2042024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Waterreus RJ; Oosterhuis HJ
    Clin Chim Acta; 1984 Sep; 142(1):103-11. PubMed ID: 6478619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores.
    Hagey LR; Crombie DL; Espinosa E; Carey MC; Igimi H; Hofmann AF
    J Lipid Res; 1993 Nov; 34(11):1911-7. PubMed ID: 8263415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Poupon RE; Ouguerram K; Chrétien Y; Verneau C; Eschwège E; Magot T; Poupon R
    Hepatology; 1993 Apr; 17(4):577-82. PubMed ID: 8477962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 37. Ursodeoxycholic acid, chenodeoxycholic acid, and 7-ketolithocholic acid are primary bile acids of the guinea pig.
    Tint GS; Xu GR; Batta AK; Shefer S; Niemann W; Salen G
    J Lipid Res; 1990 Jul; 31(7):1301-6. PubMed ID: 2401860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.
    Stiehl A; Raedsch R; Rudolph G; Walker S
    Hepatology; 1984; 4(1):107-11. PubMed ID: 6693062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
    Invernizzi P; Setchell KD; Crosignani A; Battezzati PM; Larghi A; O'Connell NC; Podda M
    Hepatology; 1999 Feb; 29(2):320-7. PubMed ID: 9918905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.